Rosiglitazone, an old diabetes drug is active on hbsag lowering and synergistic with nucs and interferon.these are the drugs to study not stupid nucs that acts on hbvdna only making mutations.
on the contrary studies on these cheap and generic durgs are not funded by drug makers, on the contrary we see stupid doctors without trials or studies saying now that these drugs can make liver damage while it is the opposite.
In addition she maintained 30 minutes of aerobic exercise 5-7 days a week most weeks since diagnosis. In July, 2010, despite compliance to treatment, she was not improving as we expected and we began to be concerned about her ability to start school and extracurricular activities. She started midodrine in July, 2010 beginning with 2.5 mg dose three times a day progressing to 7.5 mg three times a day until early August.
did they give you MRI metal, Gadolinium metal? fda gov blackbox warning? no mention of metal? see mri side effects, willis law firm, ignore him, he won't take case unless NSF diagnosis by skin doc, but you can have retained metal that dechelates or is retained if told to take iron, zinc , copper, etc, read rsna org, auntminnie com and fiercebiotech com sites, see fda gov and nyas org, free registration, Fourth Annual NSF conference, e briefing 13 Sept 2010.
I know that it still hasnt been approved byy the FDA but I read that if added to the combo therapy, it can make the chances go up for a SVR....
the opportunity to submit comments to FDA hearing FDA-2010-N-0107 on expanding early-access to DAA drugs is about to close. The hearing docket now includes a full transcript of the hearing held on April 30 and a number of interesting comments by drug manufacturers and advocacy groups. However only a couple of patient comments have been submitted.
Recommended
